| |
 |
|
|
|
|
| |
 |
|
|
Corporate Compliance and Policy Statement (updated 7/1/2008).
The primary mission of Luitpold Pharmaceuticals, Inc. and its divisions, American Regent, Inc., Osteohealth Company, and Luitpold Animal Health, is to provide safe, effective, high quality pharmaceutical products in accordance with all local, state and federal laws and regulations and in conformity with Luitpold's stringent internal quality standards. Consistent with this mission, Luitpold is committed to ethical business practices.
Luitpold has developed a comprehensive compliance program. As such, based upon a good faith belief and understanding of certain legal requirements, Luitpold Pharmaceuticals, Inc. hereby declares the Company's compliance with the law established by the California state legislature in SB 1765 (California Compliance Law) as codified at Cal. Health and Safety Code Sec. 119400-119402, and the standards recommended by Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers.
Additional information regarding Luitpold Pharmaceutical's compliance program may be found by clicking on the link that appears below
Luitpold Compliance Program Booklet.pdf
If you have questions regarding the company's compliance program, or would like a copy, please contact us at:
Compliance Officer
Luitpold Pharmaceuticals, Inc.
PO Box 9001
Shirley, NY 11967
800-645-1706 |
|
|
|
